With over 20 years in large pharma and biotech companies, Helen brings proven success in the development of innovative strategies and the delivery of projects to key milestones. Leader of global, multidisciplinary teams in CMC, diagnostics, clinical research and across the R&D sphere.
Visiting academic in infectious diseases at the University of Oxford and, recently, the Head of Pharmaceutical Development at Ziarco, which was acquired by Novartis in 2017.
Helen held a range of positions in Pfizer, including global lead roles in infectious and respiratory diseases, followed by roles in multiple start-up companies and academia, enabled by degrees in Chemical and Pharmaceutical Science and an MBA.
Board member of the Academy of Pharmaceutical Science, elected in 2008, Faculty Fellow of the Royal Pharmaceutical Society, a Chartered Chemist and Chartered Scientist.